LORALEE ROMANO: Open Payments
NPI 1336864214 · WADSWORTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 36 payments from 11 companies in 2025. Trend: 2023 $389 · 2024 $281 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $164 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Novo Nordisk Inc | 4 | $69 |
| Lilly USA, LLC | 2 | $40 |
| Ascensia Diabetes Care Us Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
| Seqirus USA Inc | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: UBRELVY, TRELEGY ELLIPTA, QULIPTA, Ozempic, JARDIANCE, MOUNJARO, Veozah, Flucelvax.
Industry payments across OH — which companies pay providers there.
